In 2008, Gregg Gellman, currently Garwood’s Vice President and Chief Operating Officer, had a vision that led to the creation of a new generation of programmable, monitored infection control devices. Working alongside leading Western New York orthopaedic and neurosurgeons, Mr. Gellman observed numerous orthopaedic and spinal surgeries. He noted that patients with certain risk profiles had difficulty with wound healing and bone regeneration. While many suffered for years with chronic wounds, others with certain co-morbidities had post-operative acute infections that were difficult to treat effectively.
Over the next few years, Mr. Gellman fabricated and prototyped various novel wound care devices, with the goal of advancing infection control, aspiring to provide more positive clinical outcomes for patients suffering from wounds and various infections resulting from post-operative complications.
In 2013, Mr. Gellman was introduced to Wayne Bacon, a Western New York businessman who has successfully led technology driven companies. Through their conversations on infections and wound care, Mr. Bacon gained an understanding and true appreciation of the intrinsic health care need that Mr. Gellman’s technologies addressed. Mr. Bacon shared Mr. Gellman’s vision and in 2014 they formed Garwood Medical Devices LLC.
Mr. Bacon, President and Chief Executive Officer of Garwood Medical, tirelessly drove the business, co-filing three patents with Mr. Gellman, and negotiating three exclusive licenses covering University at Buffalo technologies that are crucial to our core mission.
A strategic alignment with the Buffalo Institute for Genomics and Data Analytics “BIG”, was next. BIG is Governor Cuomo’s New York State-sponsored initiative and a partnership that includes the University at Buffalo, Roswell Park Cancer Institute, life sciences companies and the New York Genome Center in Manhattan. The intent is to develop new ways to treat, prevent and manage serious diseases using genomic medical research.
This strategic partnership provides Garwood Medical with a state of the art research and development site and a robust university engineering team. This public-private partnership will drive Garwood’s and UB’s technologies through development, by performing all aspects of research, device modeling, rational product design and prototyping, focusing on verifications, validations and characterizations of the applications and imbedded technologies.
Mr. Bacon was successful in having Garwood accepted into StartUp NY, which
provides NYS sales and income tax-free status to the company and investors for
10 years, and income-tax-free status for employees for the same period.
Through their collective vision and complimentary skill sets, Mr. Bacon and Mr. Gellman together, with the support from the University at Buffalo are positioned to lead Garwood Medical Devices to success.
Garwood Medical is an advanced medical device company whose products will positively enhance clinical outcomes related to infection. Through advanced technology and novel designs, Garwood Medical is committed to disrupt the wound care and perio-prosthetic market by advancing infection control through innovation.